East London heart disease initiative shortlisted for NICE award
An east London health initiative that has helped prevent 37 heart attacks and deaths in the area in the last year has been shortlisted for a prestigious NICE award.
Using guidance from the National Institute for Health and Care Excellence (NICE), the local project encouraged doctors across the boroughs of Tower Hamlets, Newham and Hackney to prescribe anti-cholesterol drugs called statins to their patients who were already known to have angina or to those who had previously had a heart attack. This was to reduce the risks of them suffering from further heart attacks or strokes later in life.
Cardiovascular disease (CVD) is a particular problem in east London, where more people suffer from the condition than anywhere else in the city.
By helping doctors implement NICE's clinical guideline, statin prescribing to those at risk of a heart attack or stroke increased from 65% in 2004 to 93% in 2010 across Tower Hamlets, Newham and Hackney primary care trusts. The areas now also have some of the best levels of statin prescription in England and Wales at low cost. This is because the project promoted the use of the generic statin, simvastatin - a cheaper alternative to branded products which offers the same clinical benefits. As a result, 4,000 extra people are now on statins and there have been 37 fewer heart attacks or deaths from the condition in the last year.
The project, which was led by the Clinical Effectiveness Group (CEG) at London's Queen Mary University (QMUL), has been shortlisted for a NICE Shared Learning Award, as an example of NICE guidance in practice. The winner will be announced on Tuesday (10 May) at NICE's Annual Conference in Birmingham.
Dr John Robson, a GP in Tower Hamlets, senior lecturer at QMUL and lead of the CEG said: "As east London has the highest rate of heart disease in the capital, it was crucial that health professionals in the area were aware of the best advice and resources on how to lower the blood cholesterol levels of their patients who were most at risk. This included south Asian people and those with unhealthy lifestyles.
"By working with hospital consultants, GPs, prescribing advisors and commissioners, we provided all 150 practices in the area with educational materials and a summary of the NICE recommendations. We also met with practices to determine their individual implementation needs and provided in-house support to those performing less well.
"Tower Hamlets, Newham and Hackney PCTs now have among the highest prescribing rates of statins in England and Wales.
"While improving the health of the local population continues to be our main goal, it is a real honour to be shortlisted for the NICE Shared Learning Award. I hope that this recognition encourages even more healthcare settings across the NHS to take note of NICE guidance and the differences that they can make."
Val Moore, Director of NICE's Implementation Programme said: "Our Shared Learning database receives hundreds of submissions every year, so for this project to be shortlisted for our annual Award is a real achievement.
"I would like to thank the Clinical Effectiveness Group in east London for sharing their success with us. It is a fantastic example of how putting NICE guidance into practice can give clear benefits to patients.
"I hope that this will now inspire others to collaborate in this fashion to deliver healthcare that is based on the best available evidence and through practical approaches tailored to each practice's particular requirements."
Notes to Editors
About cardiovascular disease (CVD)
1. CVD is the leading cause of death in the UK. In 2009, it caused over 180,000 deaths. For further statistics, please visit: www.bhf.org.uk/idoc.ashx?docid=58ce2f6a-a430-47d8-9947-2cad70536800&version=-1.
2. Angina is a pain or heaviness felt in the chest and usually caused by coronary heart disease. In some cases the discomfort may affect people in the arm, neck, stomach or jaw. Symptoms can also include shortness of breath.
3. More people in east London die from heart disease than anywhere else in the city.
|Age-standardised death rates per 100,000 from coronary heart disease for under-75s, 2006-2008|
|Kensington & Chelsea||34.81||11.77|
For further information and comparisons, please visit: www.bhf.org.uk/idoc.ashx?docid=58ce2f6a-a430-47d8-9947-2cad70536800&version=-1
About the shortlisted project
1. The Clinical Effectiveness Group (CEG) at London's Queen Mary University has been shortlisted for a NICE Shared Learning Award 2011 for its project, “Statins for Ischaemic heart disease: Excellence and equity”.
2. For this project, CEG supported 150 practices across Tower Hamlets, Newham and Hackney PCTs to implement NICE clinical guideline 67 on “Lipid modification: Cardiovascular risk assessment and modification of blood lipids for the primary and secondary prevention of cardiovascular disease”. For further information about the project, please visit: www.nice.org.uk/usingguidance/sharedlearningimplementingniceguidance/examplesofimplementation/eximpresults.jsp?o=425.
3. For further information about NICE clinical guideline 67, please visit: www.nice.org.uk/CG67. In particular pages 18 to 23 of the NICE guideline detail the recommendations regarding the use of statins for primary and secondary prevention.
About NICE's Shared Learning Awards
1. The NICE Shared Learning Awards recognise and reward examples of how NICE guidance has been put into practice in the NHS, local authorities, voluntary and other organisations.
2. The three shortlisted projects for 2011 are:
i. Statins for ischaemic heart disease: Excellence and equity - East London Clinical Effectiveness Group.
ii. Bringing the benefits of Home Haemodialysis Home - Central Manchester Foundation Trust.
iii. Stop the Clot: Implementation of extended thromboprophylaxis in patients undergoing major abdominal and pelvic cancer surgery - Sheffield Teaching Hospitals NHS Trust.
3. The winner will be chosen by attendees at NICE's Annual Conference on Tuesday 10 May 2011. The winner will receive a trophy and runners-up will be presented with certificates.
4. For further information about the Shared Learning Awards, please visit: http://www.nice.org.uk/usingguidance/sharedlearningimplementingniceguidance/sharedlearningawards/about.jsp
5. For further information about the NICE Annual Conference 2011, please visit: http://www.niceconference.org.uk/home
1. The National Institute for Health and Care Excellence (NICE) is the independent organisation responsible for providing national guidance and standards on the promotion of good health and the prevention and treatment of ill health
2. NICE produces guidance in three areas of health:
- public health - guidance on the promotion of good health and the prevention of ill health for those working in the NHS, local authorities and the wider public and voluntary sector
- health technologies - guidance on the use of new and existing medicines, treatments, medical technologies (including devices and diagnostics) and procedures within the NHS
- clinical practice - guidance on the appropriate treatment and care of people with specific diseases and conditions within the NHS
3. NICE produces standards for patient care:
- quality standards - these reflect the very best in high quality patient care, to help healthcare practitioners and commissioners of care deliver excellent services
- Quality and Outcomes Framework - NICE develops the clinical and health improvement indicators in the QOF, the Department of Health scheme which rewards GPs for how well they care for patients
4. NICE provides advice and support on putting NICE guidance and standards into practice through its implementation programme, and it collates and accredits high quality health guidance, research and information to help health professionals deliver the best patient care through NHS Evidence.
This page was last updated: 09 May 2011